The immunoassay and clinical chemistry market is the highest share contributor for the total in vitro diagnostics (IVD) market. Globally valued at $28.7 billion in 2019, this market segment contributes 37.6% of the total IVD market of $76.3 billion. Within the high-medium to low analyzer segment, there are over 40 companies globally. Of these, 14 companies are benchmarked in this study. Point of care testing is not included in this study.
The market concentration is relatively high amidst the Tier I companies, which includes Siemens Healthineers, Roche Diagnostics, Abbott Diagnostics, Beckman Coulter, and Ortho Clinical Diagnostics. Some evolving trends include an interest in small scale analyzers and niche/specialty reagents. There is also a need to establish references that generate a push to single-vendor system across a healthcare system. There is heavy focus on automation to address sample management, especially in pediatric hospitals, and there is an interest in adding third-party niche assays to existing platforms.
Finally, there is a need for constant research and development (R&D) innovation to add a new pipeline of assays in areas such as brain injury, hs- troponin (particularly in the United States), sepsis, and other potential applications of PCT, ischemic stroke, and kidney disease.
The report provides global market share, market size, and brand penetration and pricing/discounts on popular vendors and models from FY 2018 to FY 2019.
The companies that are profiled in this report include Roche Diagnostics, Siemens Healthineers, Abbott Diagnostics, Beckman Coulter (Danaher), Ortho Clinical Diagnostics, Bio-Rad, Thermo Fisher Scientific, bioMerieux, Fujirebio, Sekisui Diagnostics, MindRay, Randox, and Sysmex. The report provides a summary of the strengths, opportunity areas, and position of these companies on the Frost Radar across the growth index and innovation index. Particular R&D activities and installed bases on analyzers and strategic expansion plans have been noted.
The Frost Radar reveals the market positioning of companies in an industry using their Growth and Innovation scores as highlighted in the Frost Radar methodology. The document presents competitive profiles on each of the companies in the Frost Radar based on their strengths, opportunities, and a small discussion on their positioning. Frost & Sullivan analyzes hundreds of companies in the industry and benchmarks them across 10 criteria on the Frost Radar, where the leading companies in the industry are then positioned. Industry leaders on both the Growth and Innovation indices are recognized as best practice recipients.
Author: Divyaa Ravishankar
Industry Overview
Industry Overview (continued)
Industry Overview (continued)
Popular Vendors and Models
Pricing and Installed Base
Global Market Share Analysis
The Frost Radar
Frost Radar—Description of Companies Plotted
Roche Diagnostics
Siemens Healthineers
Abbott Diagnostics
Ortho Clinical Diagnostics
Beckman Coulter (Danaher)
Fujirebio
Randox Laboratories
Mindray
bioMérieux
Tosoh Bioscience
Bio-Rad
Sysmex
Thermo Fisher Scientific
Sekisui Diagnostics
The Last Word—Key Takeaways
Legal Disclaimer
Frost Radar—2 Major Indices, 10 Analytical Ingredients, 1 Platform
Frost Radar—2 Major Indices, 10 Analytical Ingredients, 1 Platform (continued)
Frost Radar—C2A
Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform
Growth Index
Growth Index (GI) is a measure of a company’s growth performance and track record, along with its ability to develop and execute a fully aligned growth strategy and vision; a robust growth pipeline system; and effective market, competitor, and end-user focused sales and marketing strategies.
- Market Share (previous 3 years)
This is a comparison of a company’s market share relative to its competitors in a given market space for the previous 3 years. - Revenue Growth (previous 3 years)
This is a look at a company’s revenue growth rate for the previous 3 years in the market/industry/category that forms the context for the given Frost Radar™. - Growth Pipeline
This is an evaluation of the strength and leverage of a company’s growth pipeline system to continuously capture, analyze, and prioritize its universe of growth opportunities. - Vision and Strategy
This is an assessment of how well a company’s growth strategy is aligned with its vision. Are the investments that a company is making in new products and markets consistent with the stated vision? - Sales and Marketing
This is a measure of the effectiveness of a company’s sales and marketing efforts in helping it drive demand and achieve its growth objectives.
Innovation Index
Innovation Index (II) is a measure of a company’s ability to develop products/ services/ solutions (with a clear understanding of disruptive Mega Trends) that are globally applicable, are able to evolve and expand to serve multiple markets and are aligned to customers’ changing needs.
- INNOVATION SCALABILITY
This determines whether an organization’s innovations are globally scalable and applicable in both developing and mature markets, and also in adjacent and non-adjacent industry verticals. - RESEARCH AND DEVELOPMENT
This is a measure of the efficacy of a company’s R&D strategy, as determined by the size of its R&D investment and how it feeds the innovation pipeline. - PRODUCT PORTFOLIO
This is a measure of a company’s product portfolio, focusing on the relative contribution of new products to its annual revenue. - MEGATRENDS LEVERAGE
This is an assessment of a company’s proactive leverage of evolving, long-term opportunities and new business models, as the foundation of its innovation pipeline. - CUSTOMER ALIGNMENT
This evaluates the applicability of a company’s products/services/solutions to current and potential customers, as well as how its innovation strategy is influenced by evolving customer needs.
Significance of Being on the Frost Radar™
Companies plotted on the Frost RadarTM are the leaders in the industry for growth, innovation, or both. They are instrumental in advancing the industry into the future.
- GROWTH POTENTIAL
Your organization has significant future growth potential, which makes it a Company to Action. - BEST PRACTICES
Your organization is well positioned to shape Growth Pipeline™ best practices in your industry. - COMPETITIVE INTENSITY
Your organization is one of the key drivers of competitive intensity in the growth environment. - CUSTOMER VALUE
Your organization has demonstrated the ability to significantly enhance its customer value proposition. - PARTNER POTENTIAL
Your organization is top of mind for customers, investors, value chain partners, and future talent as a significant value provider.
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Frost Radar |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Divyaa Ravishankar |
| Industries | Healthcare |
| WIP Number | K3F6-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9825-B1,9562-B1,9571-B1,9573-B1,99C1-B1,99C6-B1,99C9-B1,99CB-B1,9568-B1,9611-B1,9627-B1 |
Frost Radar in the Immunoassay and Clinical Chemistry Market
A Measurement System to Spark Companies 2 Action (C2A)—Innovation That Fuels New Deal Flow and Growth Pipelines
23-Sep-2019
North America
Frost Radar
